Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Items 201–300 of 999
Hannan, E. L., Zhong, Y., Walford, G., Holmes, D. R., Venditti, F. J., Berger, P. B., Jacobs, A. K., Stamato, N. J., Curtis, J. P., Sharma, S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.074 · Cited by 64
Self-citationMancini, G. B. J., Farkouh, M. E., Brooks, M. M., Chaitman, B. R., Boden, W. E., Vlachos, H., Hartigan, P. M., Siami, F. S., Sidhu, M. S., Bittner, V., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.021 · Cited by 64
Self-citationCurrent concepts in coronary artery revascularisation
Gaudino, M. F. L., Andreotti, F., & Kimura, T. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00459-2 · Cited by 81
Zimmermann, F. M., Ding, V. Y., Pijls, N. H. J., Piróth, Z., van Straten, A. H. M., Szekely, L., Davidavičius, G., Kalinauskas, G., Mansour, S., Kharbanda, R. K., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065770 · Cited by 68
Farooq, V., Vergouwe, Y., Généreux, P., Bourantas, C. V., Palmerini, T., Caixeta, A. M., García‐García, H. M., Diletti, R., Morel, M., McAndrew, T., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.04.004 · Cited by 68
Zhu, P., Zhou, P., Sun, Y., Guo, Y., Mai, M., & Shaoyi, Z. (2015) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-015-0262-5 · Cited by 62
“Conversely, CABG is a relatively aggressive surgical procedure with a higher risk of postoperative stroke [1,3-5], and conduits via the saphenous vein graft have comparatively short-term patency [6,7].”
BackgroundThe Hybrid Coronary Approach for Optimal Revascularization
Moreno, P., Stone, G. W., Gonzalez-Lengua, C. A., & Puskas, J. D. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.078 · Cited by 78
Management and outcomes of acute myocardial infarction in patients with chronic kidney disease
Smilowitz, N. R., Gupta, N., Guo, Y., Mauricio, R., & Bangalore, S. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.026 · Cited by 66
Vascular Tissue Engineering: Effects of Integrating Collagen into a PCL Based Nanofiber Material
Bertram, U., Steiner, D., Poppitz, B., Dippold, D., Köhn, K., Beier, J. P., Detsch, R., Boccaccini, A. R., Schubert, D. W., Horch, R. E., et al. (2017) · BioMed Research International · doi:10.1155/2017/9616939 · Cited by 62
Second Arterial Versus Venous Conduits for Multivessel Coronary Artery Bypass Surgery in California
Goldstone, A. B., Chiu, P., Baiocchi, M., Wang, H., Lingala, B., Boyd, J. H., & Woo, Y.-P. J. (2017) · Circulation · doi:10.1161/circulationaha.117.030959 · Cited by 63
Personalized treatment for coronary artery disease patients: a machine learning approach
Bertsimas, D., Orfanoudaki, A., & Weiner, R. B. (2020) · Health Care Management Science · doi:10.1007/s10729-020-09522-4 · Cited by 80
Clinical and Angiographic Results After Hybrid Coronary Revascularization
Halkos, M. E., Walker, P. F., Vassiliades, T. A., Douglas, J. S., Devireddy, C. M., Guyton, R. A., Finn, A. V., Rab, S. T., Puskas, J. D., & Liberman, H. A. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.08.041 · Cited by 62
“Although the benefits of CABG are well established [17, 18], the key limitations include the failure rate of saphenous vein grafts and the higher procedural morbidity rate compared with PCI, including stroke, sternal complications, and bleeding complications.”
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial
Esper, R. B., Farkouh, M. E., Ribeiro, E. E., Hueb, W., Domanski, M., Hamza, T. H., Siami, F. S., Godoy, L. C., Mathew, V., French, J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.046 · Cited by 61
“Specifically, the FREEDOM (Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease) trial showed a reduction in mortality and in the primary composite outcomes of death, myocardial infarction (MI), or stroke following CABG compared with PCI (3).”
BackgroundMethodSelf-citationChang, M., Ahn, J., Lee, C. W., Cavalcante, R., Sotomi, Y., Onuma, Y., Tenekecioğlu, E., Han, M., Park, D., Kang, S., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.034 · Cited by 64
“This finding is consistent with the results of previous randomized trials (7,9,13,14).”
BackgroundResultBenoit, M. A., Bagshaw, S. M., Norris, C. M., Zibdawi, M., Chin, W. D., Ross, D. B., & van Diepen, S. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002434 · Cited by 60
Bangalore, S., Maron, D. J., Fleg, J. L., O’Brien, S. M., Herzog, C. A., Stone, G. W., Mark, D. B., Spertus, J. A., Alexander, K. P., Sidhu, M. S., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.07.023 · Cited by 61
Mack, M. J., Head, S. J., Holmes, D. R., Ståhle, E., Feldman, T. E., Colombo, A., Morice, M., Unger, F., Ērglis, A., Stoler, R., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.11.010 · Cited by 64
Self-citationAssessing quality-of-life outcomes in cardiovascular clinical research
Mark, D. B. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.10 · Cited by 68
Fersis, N., Gruber, I. V., Relakis, K., Friedrich, M., Becker, S., Wallwiener, D. R., & Wagner, U. A. (2004) · PubMed · Cited by 59
Zhang, Y., Iqbal, J., Campos, C. M., Klaveren, D. V., Bourantas, C. V., Dawkins, K. D., BANNING, A. P., Escaned, J., de Vries, T., Morel, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.022 · Cited by 66
“MACCE Death or stroke or MI All-cause death Cardiac death Stroke MI Repeat revascularization 'Site' SYNTAX score (20-27)”
BackgroundResultdel Blanco, B. G., Hernández, F., Cuevas, J. R. R., & Trillo, R. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.08.005 · Cited by 57
Biological Materials for Tissue-Engineered Vascular Grafts: Overview of Recent Advancements
Francesco, D. D., Pigliafreddo, A., Casarella, S., Nunno, L. D., Mantovani, D., & Boccafoschi, F. (2023) · Biomolecules · doi:10.3390/biom13091389 · Cited by 63
“Autologous blood vessels are naturally biocompatible, non-thrombogenic, and have the necessary mechanical properties to suit vascular application [4].”
BackgroundUse of the Hybrid Operating Room in Cardiovascular Medicine
Kaneko, T., & Davidson, M. (2014) · Circulation · doi:10.1161/circulationaha.114.006510 · Cited by 57
Fearon, W. F., Zimmermann, F. M., Ding, V. Y., Takahashi, K., Piróth, Z., van Straten, A. H. M., Szekely, L., Davidavičius, G., Kalinauskas, G., Mansour, S., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00505-7 · Cited by 76
Cost-Effectiveness of Revascularization Strategies
Zhang, Z., Kolm, P., Grau‐Sepulveda, M. V., Ponirakis, A., O’Brien, S. M., Klein, L. W., Shaw, R. E., McKay, C. R., Shahian, D. M., Grover, F. L., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.078 · Cited by 66
Interactions Between Morphological Plaque Characteristics and Coronary Physiology
Yang, S., Koo, B., & Narula, J. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.10.009 · Cited by 63
Teo, K. K., Cohen, E. A., Buller, C. E. H., Hassan, A., Carere, R. G., Cox, J. L., Ly, H. Q., Fedak, P. W. M., Chan, K. L., Légaré, J., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.034 · Cited by 65
van Diepen, S., Graham, M. M., Nagendran, J., & Norris, C. M. (2014) · Critical Care · doi:10.1186/s13054-014-0651-5 · Cited by 66
“Introduction Coronary artery bypass grafting (CABG) and valvular surgery improve patient survival and quality of life [1-3].”
BackgroundZheng, Z., Xu, B., Zhang, H., Guan, C., Xian, Y., Zhao, Y., Fan, H., Yang, Y., Wang, W., Gao, R., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.03.039 · Cited by 54
O’Fee, K., Deych, E., Ciani, O., & Brown, D. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.5726 · Cited by 59
Myocardial Revascularization Surgery
Mack, M. J., Squiers, J. J., Lytle, B. W., DiMaio, J. M., & Mohr, F. W. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.099 · Cited by 59
Self-citationImpact of myocardial injury after coronary artery bypass grafting on long-term prognosis
Pölzl, L., Thielmann, M., Cymorek, S., Nägele, F., Hirsch, J., Graber, M., Sappler, N., Eder, J., Staggl, S., Theurl, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac054 · Cited by 57
Acute Kidney Injury After CABG Versus PCI
Chang, T. I., Leong, T. K., Boothroyd, D. B., Hlatky, M. A., & Go, A. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.077 · Cited by 57
“In the Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease Trial (40), 8 patients with diabetes and multivessel coronary disease randomized to receive CABG underwent dialysis within 30 days of revascularization, compared with only 1 patient in the PCI group…”
MethodInfluentialErtelt, K., Généreux, P., Mintz, G. S., Reiss, G. R., Kirtane, A. J., Madhavan, M. V., Fahy, M. P., Williams, M. R., Brener, S. J., Mehran, R., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.07.038 · Cited by 53
Chan, W., Ivanov, J., Ko, D. T., Fremes, S. E., Rao, V., Jolly, S. S., Cantor, W. J., Lavi, S., Overgaard, C. B., Ruel, M., et al. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001973 · Cited by 53
Characteristics of coronary artery disease in chronic kidney disease
Fujii, H., Kono, K., & Nishi, S. (2019) · Clinical and Experimental Nephrology · doi:10.1007/s10157-019-01718-5 · Cited by 65
Ferguson, T. B., Chen, C., Babb, J. D., Efird, J. T., Daggubati, R. B., & Cahill, J. M. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.06.026 · Cited by 52
Zhang, L., Wu, W., Ma, H., & Wang, H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.277 · Cited by 52
“Several randomized controlled trials have addressed the comparative benefits of PCI and CABG in these patients [18,20,21].”
BackgroundLee, C. W., Ahn, J., Cavalcante, R., Sotomi, Y., Onuma, Y., Suwannasom, P., Tenekecioğlu, E., Yun, S., Park, D., Kang, S., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.10.008 · Cited by 64
“We excluded 4 trials from the study: the FREEDOM study investigators did not participate in this collaborative analysis (10), and the CARDia (Coronary Artery Revascularization in Diabetes) trial used both DES and bare-metal stents (11), and 2 small trials had no longterm outcomes published (12,13).”
Methodvan Diepen, S., Fuster, V., Verma, S., Hamza, T. H., Siami, F. S., Goodman, S. G., & Farkouh, M. E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.043 · Cited by 54
“The methods and results of the FREEDOM trial have been published (1,21).”
MethodSelf-citationMuramatsu, T., Onuma, Y., van Geuns, R., Chevalier, B., Patel, T. M., Seth, A., Diletti, R., García‐García, H. M., Dorange, C., Veldhof, S., et al. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.01.155 · Cited by 51
Do Current Clinical Trials Meet Society’s Needs?
Pocock, S., & Gersh, B. J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.08.008 · Cited by 51
Self-citationPredicting 3-Year Mortality After Percutaneous Coronary Intervention
Iqbal, J., Vergouwe, Y., Bourantas, C. V., Klaveren, D. V., Zhang, Y., Campos, C. M., García‐García, H. M., Morel, M., Valgimigli, M., Windecker, S., et al. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.02.007 · Cited by 59
Nicolau, J. C., Timerman, A., Marin‐Neto, J. A., Piegas, L. S., Dornas, C. J. C. B., Franci, A., Avezum, A., Carvalho, A., Filho, B. M., Polanczyk, C. A., et al. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2014s001 · Cited by 104
Nicolini, F., Contini, G. A., Fortuna, D., Pacini, D., Gabbieri, D., Vignali, L., Campo, G. C., Manari, A., Zussa, C., Guastaroba, P., et al. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.09.019 · Cited by 51
del Blanco, B. G., Hernández, F., Cuevas, J. R. R., & Trillo, R. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.08.005 · Cited by 50
“The publication of the FREEDOM trial 34 and the presentation of the long-term results of the SYNTAX trial, 35 published in 2013, 36 have probably discouraged the treatment of multivessel disease in patients with complex anatomy, especially diabetics.”
van Diepen, S., Norris, C. M., Zheng, Y., Nagendran, J., Graham, M. M., Ortega, D. G., Townsend, D. R., Ezekowitz, J. A., & Bagshaw, S. M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009917 · Cited by 50
Göbölös, L., Ramahi, J., Obeso, A., Bartel, T., Hogan, M. P., Traina, M. I., Edris, A., Hasan, F., Banna, M. E., Tuzcu, E. M., et al. (2019) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1177/1556984519827703 · Cited by 50
Wang, R., Serruys, P. W. J. C., Gao, C., Hara, H., Takahashi, K., Ono, M., Kawashima, H., O’Leary, N., Holmes, D. R., Witkowski, A., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab441 · Cited by 61
Self-citationOptimizing Management of Stable Angina
Montone, R. A., Rinaldi, R., Niccoli, G., Andò, G., Gragnano, F., Piccolo, R., Pelliccia, F., Moscarella, E., Zimarino, M., Fabris, E., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.015 · Cited by 55
Revascularization in Severe Left Ventricular Dysfunction
Velazquez, E. J., & Bonow, R. O. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.070 · Cited by 49
Tiroch, K. A., Mehilli, J., Byrne, R. A., Schulz, S., Maßberg, S., Laugwitz, K., Vorpahl, M., Seyfarth, M., & Kastrati, A. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.08.013 · Cited by 49
Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor
Norhammar, A., Mellbin, L., & Cosentino, F. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317709554 · Cited by 49
“Since the evidence is sparse, the most recent guidelines on revascularisation state that the assessment of viability should not be the sole factor when deciding on the best strategy for patients with severe left ventricular function and evident CAD.(39) Lifestyle intervention”
InfluentialKajimoto, K., Yamamoto, T., & Amano, A. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.09.045 · Cited by 48
Status Quo of Hybrid Coronary Revascularization for Multi-Vessel Coronary Artery Disease
Harskamp, R. E., Zheng, Z., Alexander, J. H., Williams, J. B., Xian, Y., Halkos, M. E., Brennan, J. M., de Winter, R. J., Smith, P. K., & Lópes, R. D. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.07.093 · Cited by 48
“The optimal revascularization strategy remains controversial, and depends on the anatomic complexity of the lesions requiring revascularization, comorbidities, and the ability to use dual antiplatelet therapy [2, 3].”
BackgroundPapafaklis, M. I., Bourantas, C. V., Yonetsu, T., Vergallo, R., Kotsia, A. P., Nakatani, S., Lakkas, L. S., Athanasiou, L. S., Naka, K. Κ., Fotiadis, D. I., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m06_11 · Cited by 48
Cerebrovascular Events After Cardiovascular Procedures
Devgun, J. K., Gul, S., Mohananey, D., Jones, B., Hussain, M. S., Jobanputra, Y. B., Kumar, A., Svensson, L. G., Tuzcu, E. M., & Kapadia, S. R. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.065 · Cited by 48
Romaguera, R., Salinas, P., Lara, J. G., Brugaletta, S., Gómez-Menchero, A. E., Romero, M., García‐Blas, S., Ocaranza, R., Bordes, P., Kockar, M. J., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab790 · Cited by 54
Percutaneous Coronary Intervention for Left Main Coronary Artery Disease
Park, S., Park, S., & Park, D. (2022) · JACC Asia · doi:10.1016/j.jacasi.2021.12.011 · Cited by 53
“2 , 2 0 2 2 Park et al A P R I L 2 0 2 2 : 1 1 9 – 1 3 8 PCI for Left Main Disease 129 LCX ostium by the noncoaxial orientation of the catheter from an LAD pull back.95 The other important value of IVUS is to ensure stent optimization of LMCA PCI.”
InfluentialAli, J. A., Franck, C., Filion, K. B., & Eisenberg, M. J. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.12.202 · Cited by 47
Bundhun, P. K., Wu, Z. J., & Chen, M. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0323-z · Cited by 50
“Farkouh [11] 1, 2, 5 Death, MACCEs, MI, stroke, repeated revascularization”
Feres, F., Ra, C., Siqueira, D., Costa, J., Jr., Chamié, D., Staico, R., Aj, C., Abizaid, A., Marin‐Neto, J. A., Rassi, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170111 · Cited by 58
Kok, M. M., von Birgelen, C., Sattar, N. A., Zocca, P., Löwik, M. M., Danse, P. W., Schotborgh, C. E., Scholte, M., Hartmann, M., Kant, G. D., et al. (2018) · EuroIntervention · doi:10.4244/eij-d-17-01067 · Cited by 50
del Blanco, B. G., Cuevas, J. R. R., Hernández, F., & Trillo, R. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.08.001 · Cited by 46
The adequacy of myocardial revascularization in patients with multivessel coronary artery disease
Zimarino, M., Curzen, N. P., Cicchitti, V., & Caterina, R. D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.05.004 · Cited by 53
“These results were confirmed in the Future REvascularization Evaluation in patientswith diabetesmellitus: Optimalmanagement of Multivessel disease (FREEDOM) trial [69], where 1900 patients with diabetes and MVCAD were randomized to DES-PCI or CABG.”
ResultIn-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty
Salisbury, A. C., Karmpaliotis, D., Grantham, J. A., Sapontis, J., Meng, Q., Magnuson, E. A., Gada, H., Lombardi, W. L., Moses, J. W., Li, H., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.10.025 · Cited by 46
“The procedural costs of CTO PCI in the present study ($12,280 $5,972) are similar to the costs of multivessel or left main PCI in the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) ($11,919 $6,162) and FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of M…”
MethodSelf-citationPercutaneous Coronary Revascularization
Serruys, P. W. J. C., Ono, M., Garg, S., Hara, H., Kawashima, H., Pompilio, G., Andreini, D., Holmes, D. R., Onuma, Y., & King, S. B. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.024 · Cited by 50
Self-citationBeyond Conventional Operations: Embracing the Era of Contemporary Minimally Invasive Cardiac Surgery
Ilcheva, L., Risteski, P. S., Tudorache, I., Häussler, A., Papadopoulos, N., Odavic, D., Biefer, H. R. C., & Dzemali, O. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237210 · Cited by 53
“However, PCI has also been associated with increased intervention rates in patients with multivessel disease and coexisting conditions, such as diabetes mellitus [57,58].”
Backgrounddel Blanco, B. G., Cuevas, J. R. R., Hernández, F., & Trillo, R. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.08.001 · Cited by 45
Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus
Kedhi, E., Kennedy, M., Maehara, A., Lansky, A. J., McAndrew, T., Marso, S. P., Bruyne, B. D., Serruys, P. W. J. C., & Stone, G. W. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.12.023 · Cited by 48
“Our results also suggest a mechanistic explanation for the greater rates of MACE after PCI in patients with DM (3,14) and explain why coronary artery bypass graft surgery (CABG) may be superior to PCI in diabetic patients with extensive coronary artery disease (15,16).”
ResultSelf-citationSex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization
Piña, I. L., Zheng, Q., She, L., Szwed, H., Lang, I. M., Farsky, P. S., Castelvecchio, S., Biernat, J., Paraforos, A., Kosevic, D., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030526 · Cited by 45
Marui, A., Kimura, T., Nishiwaki, N., Mitsudo, K., Komiya, T., Hanyu, M., Shiomi, H., Tanaka, S., & Sakata, R. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.544 · Cited by 48
Top 10 cardiovascular therapies and interventions for the next decade
Fuster, V. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.137 · Cited by 50
Self-citationIribarne, A., Schmoker, J. D., Malenka, D. J., Leavitt, B. J., McCullough, J. N., Weldner, P. W., DeSimone, J. P., Westbrook, B. M., Quinn, R. D., Klemperer, J. D., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027405 · Cited by 44
Weidner, K., Behnes, M., Schupp, T., Rusnak, J., Reiser, L., Bollow, A., Taton, G., Reichelt, T., Ellguth, D., Engelke, N., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0768-y · Cited by 44
Katz, D. H., & Gavin, M. C. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201908060 · Cited by 55
Nyström, T., Holzmann, M. J., Eliasson, B., Kuhl, J., & Sartipy, U. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.054 · Cited by 43
“These patients were therefore at high risk for death or MACE, as confirmed by the high incidence of these outcomes, an incidence higher than that reported in another recently published study (30).”
ResultOptimal revascularization for complex coronary artery disease
Iqbal, J., Serruys, P. W. J. C., & Taggart, D. P. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.138 · Cited by 46
Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial
Taggart, D. P., Altman, D. G., Gray, A. M., Lees, B., Nugara, F., Yu, L., Flather, M. D., & on behalf of the ART Investigators (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu349 · Cited by 43
Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease
Modolo, R., Chichareon, P., Kogame, N., Dressler, O., Crowley, A., Ben‐Yehuda, O., Puskas, J. D., BANNING, A. P., Taggart, D. P., Kappetein, A. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.090 · Cited by 49
Coronary Stents: The Impact of Technological Advances on Clinical Outcomes
Mennuni, M. G., Pagnotta, P. A., & Stefanini, G. G. (2015) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1399-z · Cited by 42
Caixeta, A. M., Généreux, P., Palmerini, T., Lansky, A. J., Mehran, R., Dangas, G., Xu, K., Brener, S. J., & Stone, G. W. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.035 · Cited by 42
Self-citationPalmerini, T., Biondi‐Zoccai, G., Riva, D. D., Mariani, A., Savini, C., Eusanio, M. D., Généreux, P., Frati, G., Marullo, A. G. M., Landoni, G., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.011 · Cited by 42
Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Diabetes
Salisbury, A. C., Sapontis, J., Grantham, J. A., Qintar, M., GOSCH, K. L., Lombardi, W. L., Karmpaliotis, D., Moses, J. W., Cohen, D. J., Spertus, J. A., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.08.043 · Cited by 49
“Although coronary artery bypass graft surgery (CABG) is the preferred method of revascularization in patients with diabetes and multivessel disease (4,5), many patients presenting with CTOs have single-vessel disease or have previously been treated with bypass surgery.”
MethodSelf-citationRam, E., Sternik, L., Klempfner, R., Iakobishvili, Z., Peled, Y., Nir, S., & Raanani, E. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.08.130 · Cited by 48
“637 1-vessel CAD 1115 (32) 33 (6) 30 (7) 24 (5) 0.”
Piccolo, R., Pilgrim, T., Heg, D., Franzone, A., Rat-Wirtzler, J., Räber, L., Silber, S., Serruys, P. W. J. C., Jüni, P., & Windecker, S. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.08.013 · Cited by 41
“Similarly, PCI with the use of earlygeneration sirolimus- or paclitaxel-eluting stents was inferior compared with CABG among diabetic patients with multivessel disease in the randomized FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial (11…”
BackgroundMethodDisability–free survival after coronary artery bypass grafting in women and men with heart failure
Sun, L. Y., Tu, J. V., Lee, D. S., Beanlands, R. S., Ruel, M., Austin, P. C., Eddeen, A. B., & Liu, P. P. (2018) · Open Heart · doi:10.1136/openhrt-2018-000911 · Cited by 41
Standardizing definitions for hybrid coronary revascularization
Harskamp, R. E., Bonatti, J. O., Zhao, D. X.-M., Puskas, J. D., de Winter, R. J., Alexander, J. H., & Halkos, M. E. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.10.019 · Cited by 41
Drug-Coated Balloons-Based Intervention for Coronary Artery Disease
Her, A., Ahmad, W. A. W., Bang, L. H., Kiam, O. T., Nuruddin, A. A., Hsieh, C., Hwa, H. H., Yahaya, S. A., Tang, Q., Hsu, J.-C., et al. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.02.017 · Cited by 46
Luca, G. D., Schaffer, A., Verdoia, M., & Suryapranata, H. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.11.002 · Cited by 41
Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal
Goldfarb, M., Drudi, L. M., Almohammadi, M., Langlois, Y., Noiseux, N., Perrault, L. P., Piazza, N., & Afilalo, J. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002204 · Cited by 40
Brown, J. R., Rezaee, M. E., Nichols, E. L., Marshall, E. J., Siew, E. D., & Matheny, M. E. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002739 · Cited by 42
McKittrick, C. M., McKee, S., Kennedy, S., Oldroyd, K. G., Wheel, M. A., Pontrelli, G., Dixon, S., McGinty, S., & McCormick, C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.012 · Cited by 40
“However, they have not removed the problem of restenosis completely and around 6% of patients will need to return to hospital to undergo a costly repeat procedure within two years [1], with this rate more than doubling in high-risk patients, such as those with diabetes [2], and in complex lesions [3].”
BackgroundNew-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot, K., Bastos, M. B., Daemen, J., Schreuder, J. J., Boersma, E. H., Zijlstra, F., & Mieghem, N. M. V. (2019) · EuroIntervention · doi:10.4244/eij-d-18-01126 · Cited by 44
Percutaneous Coronary Intervention in Patients With Diabetes: Current Concepts and Future Directions
Armstrong, E. J., Waltenberger, J. L., & Rogers, J. H. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813517058 · Cited by 55
“The recently published FREEDOM trial randomized patients with DM and multivessel CAD to a revascularization strategy of CABG or PCI.(12) During 5-year follow-up, the group randomized to CABG had significantly lower rates of myocardial infarction (6.”
MethodInfluentialdel Blanco, B. G., Hernández, F., Cuevas, J. R. R., & Trillo, R. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.09.007 · Cited by 39
Coronary Revascularization in Diabetic Patients: Off-Pump Versus On-Pump Surgery
Renner, A., Zittermann, A., Aboud, A., Puehler, T., Hakim‐Meibodi, K., Quester, W., Tschoepe, D., Börgermann, J., & Gummert, J. F. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.04.063 · Cited by 43
“In diabetic patients with severe multi-vessel disease [4] coronary artery bypass grafting (CABG) was repeatedly proven to be superior to percutaneous interventions in terms of the risk of myocardial infarction, cardiac death, and need for repeat revascularization.”
BackgroundShould Bilateral Internal Thoracic Artery Grafting Be Used in Patients With Diabetes Mellitus?
Pevni, D., Medalion, B., Mohr, R., Ben‐Gal, Y., Laub, A., Nevo, A., Kramer, A., Paz, Y., & Nesher, N. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.06.044 · Cited by 40
“Whereas the value of a second ITA in terms of late mortality and event-free survival has been established for nondiabetic patients [7, 24], the long-term benefit of BITA grafting in patients with diabetes is a matter of debate [3, 4].”
BackgroundPercutaneous Coronary Intervention of Left Main Disease
Park, D., & Park, S. (2017) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.117.004792 · Cited by 42
Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease
Patel, N. C., Hemli, J. M., Kim, M. C., Seetharam, K., Pirelli, L., Brinster, D. R., Scheinerman, S. J., & Singh, V. P. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.04.078 · Cited by 39
“The Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease trial determined that CABG was superior to PCI for diabetic patients with advanced coronary disease, with reduced rates of death and myocardial infarction.(4) Although the role of CABG thus seems clear…”
Method
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.